Clinical Trial Detail

NCT ID NCT02306291
Title Study to Determine Safety, Pharmacokinetics and Efficacy of GMI-1271 in Combination With Chemotherapy in AML
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors GlycoMimetics Incorporated
Indications

acute myeloid leukemia

Therapies

Cytarabine + Idarubicin

Cytarabine + Etoposide + Mitoxantrone

Uproleselan

Age Groups: adult senior

No variant requirements are available.